Aastrom Biosciences, Inc.
Dominos Farms Lobby K
24 Frank Lloyd Wright Drive
Ann Arbor,
MI 48105
United States - Map
Phone: 734-418-4400
Fax: 734-665-0485
Website: http://www.aastrom.com
Aastrom Biosciences, Inc., a development stage company, engages in the development of patient-specific, cell products for use in the treatment of severe, chronic ischemic cardiovascular diseases. It is developing ixmyelocel-T, a patient-specific multicellular therapy expanded from a patient's own bone marrow and delivered directly to damaged tissues. The companys ixmyelocel-T is in late-stage clinical development, including a Phase III clinical program to study patients with critical limb ischemia and a Phase IIb clinical trial in patients with ischemic dilated cardiomyopathy. The company was founded in 1989 and is headquartered in Ann Arbor, Michigan. Key Statistics
| |
| | Pay | Exercised | Mr. Brian D. Gibson ,
34
Principal Financial Officer, Chief Accounting Officer, VP of Fin., Corp. Sec. and Treasurer | 186.00K | 0.00 | Dr. Ronnda L. Bartel Ph.D.,
54
Chief Scientific Officer | 262.00K | 0.00 | Mr. Daniel R. Orlando ,
47
Chief Bus. Officer | 100.00K | 0.00 | Dr. Sharon M. Watling PharmD,
49
Consultant | 255.00K | 0.00 | Mr. Dominick C. Colangelo Esq.,
49
Chief Exec. Officer, Pres and Director | N/A | N/A |
|
| | Amounts are as of Dec 30, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year. | | Currency in USD. |
|
0.02(3.39%) May 17, 4:00PM EDT